Interferon-gamma is necessary for initiating the acute rejection of major histocompatibility complex class II-disparate skin allografts.
暂无分享,去创建一个
Z. Dai | Fadi G Lakkis | B. Konieczny | G H Ring | S Saleem | Z Dai | A T Hassan | B T Konieczny | F K Baddoura | F G Lakkis | G. H. Ring | F. Baddoura | S. Saleem | A. Hassan
[1] A. Billiau,et al. Interferon-gamma: biology and role in pathogenesis. , 1996, Advances in immunology.
[2] A. Gaspari,et al. Induction and functional characterization of class II MHC (Ia) antigens on murine keratinocytes. , 1988, Journal of immunology.
[3] P. Linsley,et al. IFN-gamma is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways. , 1998, Journal of immunology.
[4] D. Schmitt,et al. Dissection of human Langerhans cells' allostimulatory function: The need for an activation step for full development of accessory function , 1993, European journal of immunology.
[5] A. Bradley,et al. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. , 1993, Science.
[6] A. Minty,et al. Interleukin 13 is a B cell stimulating factor , 1994, The Journal of experimental medicine.
[7] P. Nickerson,et al. Interferon-gamma receptor signaling is not required in the effector phase of the alloimmune response. , 1998, Transplantation.
[8] J. Sprent,et al. Properties of purified T cell subsets. II. In vivo responses to class I vs. class II H-2 differences , 1986, The Journal of experimental medicine.
[9] Fadi G Lakkis,et al. Acute rejection of vascularized heart allografts in the absence of IFNgamma. , 1996, Transplantation.
[10] P. Halloran,et al. The unique role of interferon-gamma in the regulation of MHC expression on arterial endothelium. , 1996, Transplantation.
[11] R. Steinman,et al. Migration and maturation of Langerhans cells in skin transplants and explants , 1990, The Journal of experimental medicine.
[12] M. Dallman,et al. Induction of Ia antigens on murine epidermal cells during the rejection of skin allografts. , 1983, Transplantation.
[13] A. Singer,et al. Specific prolongation of MHC class II disparate skin allografts by in vivo administration of anti-IFN-gamma monoclonal antibody. , 1990, Journal of immunology.
[14] A. Singer,et al. Rejection of skin allografts by CD4+ T cells is antigen-specific and requires expression of target alloantigen on Ia- epidermal cells. , 1989, Journal of immunology.